Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > Novo Nordisk to sell obesity drug Wegovy direct to patients at lower price
Health and Wellness

Novo Nordisk to sell obesity drug Wegovy direct to patients at lower price

Last updated: March 10, 2025 12:51 am
Share
Novo Nordisk to sell obesity drug Wegovy direct to patients at lower price
SHARE

Novo Nordisk has announced that it will be offering its obesity drug Wegovy directly to patients at a reduced price through its new direct-to-consumer offering called NovoCare Pharmacy. This move comes as the pharmaceutical company aims to compete for market share and draw patients away from compounding pharmacies that have been making cheaper copies of weight loss drugs.

Typically, Wegovy carries a list price of around $1,350 per month. However, Novo Nordisk will now sell the treatment for $499 a month for all doses to cash-paying patients, meaning those who are paying out of pocket without insurance. Orders will be fulfilled by CenterWell Pharmacy, a subsidiary of Humana that offers home delivery services.

This decision by Novo Nordisk comes in response to a similar move by Eli Lilly, as both drugmakers look to capture a larger share of the obesity drug market. By offering Wegovy at a reduced price directly to patients, Novo Nordisk hopes to make the treatment more accessible and affordable for those in need of weight loss medication.

The direct-to-consumer model not only benefits patients by offering a more affordable option but also allows Novo Nordisk to bypass traditional distribution channels and reach consumers directly. This strategy may help the company increase its market share and establish a stronger presence in the obesity drug market.

In conclusion, Novo Nordisk’s decision to sell Wegovy directly to patients at a reduced price through NovoCare Pharmacy is a strategic move to compete with other drugmakers and attract patients away from compounding pharmacies. By offering the treatment at a more affordable price, the company aims to make weight loss medication more accessible to those in need. This direct-to-consumer approach may prove to be successful in expanding Novo Nordisk’s reach and market share in the obesity drug market.

See also  Potential Ebola outbreak reported in DRC at a time of strained U.S.-WHO relations
TAGGED:DirectDrugNordiskNovoObesitypatientsPricesellWegovy
Share This Article
Twitter Email Copy Link Print
Previous Article Luxon announces high stakes trip to India Luxon announces high stakes trip to India
Next Article Daisy Patton Paints Wedding Photos Back to Life  Daisy Patton Paints Wedding Photos Back to Life 
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Celebrate National Pasta Day With Doughy Recreations Inspired by the Spring 2026 Runways

With fashion month now wrapped up, we’re indulging ourselves with a delightful bowl of pasta.…

October 17, 2025

It’s all about the Fed?

Today, the stock market experienced a decline, which led to discussions about the role of…

January 10, 2025

Climate of Creativity and Coproduction

The Taiwan Creative Content Fest (TCCF) recently wrapped up its fifth edition, solidifying its position…

November 10, 2024

Two Suspects Admit to Louvre Heist Involvement, Prosecutor Says 

Paris Prosecutor: Suspects Partially Admit Involvement in Louvre Jewel Heist After spending four days in…

October 29, 2025

Berkshire shares dip after earnings decline, lack of buybacks disappoint investors

Berkshire Hathaway, the conglomerate led by legendary investor Warren Buffett, recently reported a small decline…

August 4, 2025

You Might Also Like

Nearly 1 in 5 urinary tract infections linked to contaminated meat
Health and Wellness

Nearly 1 in 5 urinary tract infections linked to contaminated meat

October 31, 2025
Cigna Profits Hit Nearly  Billion Despite Rising Costs
Health and Wellness

Cigna Profits Hit Nearly $2 Billion Despite Rising Costs

October 30, 2025
For cardiac health, exercise benefits women more than men
Health and Wellness

For cardiac health, exercise benefits women more than men

October 30, 2025
Hydrogen gas found to play key role in supporting gut health
Health and Wellness

Hydrogen gas found to play key role in supporting gut health

October 30, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?